English | Change
MIGRASTICK | ADVICE FROM Dr SCHWOB | scientific data | ABOUT ESSENTIAL OILS?
Clinical tests | Other scientific references | What is a medical device?
SCIENTIFIC DATA
Clinical tests
Clinical study
An open clinical trial by ARKOPHARMA on the efficacy and tolerance of MIGRASTICK in the treatment of Migraine has been carried out (Dr. Schwob. Paris, mai 2001). 21 migraine patients were followed for 2 months (60 days): The number of migraine attacks, the length of the migraine attacks, the pain intensity (mild, strong, very strong), the concomitant take of other medicine and the subjective tolerance are recorded.
Results: 91 % satisfaction of effectiveness (percentage of patients reporting good or excellent effectiveness). 85,5 % satisfaction of tolerability (percentage of patients reporting good or excellent tolerance)
Clinical tests on the cooling effect:
The cold effect of MIGRASTICK was measured and shown in 2 scientific tests:
  • An independent laboratory (EVIC France) carried out a test by The temperature was measured objectively before and after application of MIGRASTICK by thermography. The results indicate that Migrastick has a cooling effect for a period of more than 3 minutes 30 seconds after application (October 2000).
  • An internal test was carried out by ARKOPHARMA to test the skin cooling effect of MIGRASTICK with a temperature probe (December 2000).
Temperature before & after application of Migrastick
Temperature before & after application of Migrastick
90%  of the doctors judged the efficacy and tolerance of MIGRASTICK as good or excellent.
Evaluation of efficiency and tolerance
Number of migraines
Number of migraines
Groupe Arkopharma
Copyright 2018 - All trademarks registered - All rights reserved